IRIS

Vinyl chloride

CASRN 75-01-4 | DTXSID8021434

IRIS Toxicological Review of Vinyl Chloride (Final Report)

On this page:

Overview

EPA is announcing the release of the final report, Toxicological Review of Vinyl Chloride: in support of the Integrated Risk Information System (IRIS). The updated Summary for Vinyl Chloride and accompanying Quickview have also been added to the IRIS Database.

Citation

U.S. EPA. IRIS Toxicological Review of Vinyl Chloride (Final Report). U.S. Environmental Protection Agency, Washington, DC, 2000.

Top of Page


Background

Common synonyms of vinyl chloride (VC) include chloroethene, chloroethylene, ethylene monochloride, and monochloroethene. VC is a synthetic chemical used as a chemical intermediate in the polymerization of polyvinyl chloride. At room temperature and pressure, it is a colorless gas with a mild, sweet odor. As the data shown above indicate, VC is poorly soluble in water. Structurally, VC is a haloalkene and is related to vinylidene chloride and trichloroethylene. The Draft Toxicological Review was developed to evaluate both the cancer and non cancer human health risks from environmental exposure to vinyl chloride. A reference concentration (RfC), and a reference dose (RfD) were developed based upon induction of liver cell polymorphism in a chronic dietary study utilizing Wistar rats. An RfC of 1E-1 mg/m3 and an RfD of 5E-3 mg/kg-d are recommended. On the basis of sufficient evidence for carcinogenicity in human epidemiology studies vinyl chloride is reaffirmed to be a known human carcinogen. Cancer potencies were derived for oral and inhalation exposure. An oral slope factor of 1.3 per (mg/kg-day) for continuous exposure during adulthood and 2.5 per (mg/kg-day) for continuous lifetime exposure from birth, based upon a chronic dietary study in female Wistar rats is recommended; an inhalation unit risk of 4.3 E-6 per (55g/m3) for continuous exposure during adulthood and 8.7 E-6 per (55g/m3) for continuous lifetime exposure from birth is also recommended, based upon exposure of male and female Sprague Dawley rats and Swiss mice, via inhalation, for a lifetime. A PBPK model was used in the derivation of the RfC, RfD, and cancer potency estimates. Its use is based on the assumption that equal tissue concentrations of reactive metabolite, chlorethylene oxide or chloracetaldehyde, at the critical target site will result in equivalent toxicity between species.

History/Chronology

Date Description
01- May 1999 EPA released the draft report for external peer review.
02- May 2000 EPA released the final tox report and summary document and posted these to the IRIS database.

Top of Page

Download(s)

This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use.

If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.


Top of Page